GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $440,000 | -0.7% | 10,114 | -0.5% | 0.05% | +16.3% |
| Q1 2022 | $443,000 | -2.9% | 10,164 | -1.7% | 0.04% | +7.5% |
| Q4 2021 | $456,000 | +15.4% | 10,339 | 0.0% | 0.04% | +5.3% |
| Q3 2021 | $395,000 | +0.8% | 10,339 | +5.0% | 0.04% | 0.0% |
| Q2 2021 | $392,000 | +13.0% | 9,844 | +1.4% | 0.04% | +8.6% |
| Q1 2021 | $347,000 | -2.0% | 9,709 | +1.0% | 0.04% | -10.3% |
| Q4 2020 | $354,000 | +3.8% | 9,609 | +6.1% | 0.04% | -4.9% |
| Q3 2020 | $341,000 | -8.1% | 9,059 | -0.4% | 0.04% | -16.3% |
| Q2 2020 | $371,000 | +10.1% | 9,099 | +2.2% | 0.05% | -7.5% |
| Q1 2020 | $337,000 | -19.8% | 8,904 | -0.3% | 0.05% | +1.9% |
| Q4 2019 | $420,000 | +12.0% | 8,929 | +1.6% | 0.05% | +4.0% |
| Q3 2019 | $375,000 | +10.3% | 8,789 | +3.5% | 0.05% | +6.4% |
| Q2 2019 | $340,000 | -4.8% | 8,491 | -0.5% | 0.05% | -7.8% |
| Q1 2019 | $357,000 | -10.3% | 8,531 | -18.2% | 0.05% | -17.7% |
| Q4 2018 | $398,000 | -5.0% | 10,431 | -0.1% | 0.06% | +10.7% |
| Q3 2018 | $419,000 | +2.2% | 10,446 | +2.7% | 0.06% | -6.7% |
| Q2 2018 | $410,000 | +0.2% | 10,176 | -2.7% | 0.06% | -1.6% |
| Q1 2018 | $409,000 | +10.5% | 10,461 | +0.5% | 0.06% | +17.3% |
| Q4 2017 | $370,000 | -17.4% | 10,413 | -5.5% | 0.05% | -23.5% |
| Q3 2017 | $448,000 | -6.1% | 11,019 | -0.2% | 0.07% | -8.1% |
| Q2 2017 | $477,000 | +2.6% | 11,043 | +0.0% | 0.07% | +1.4% |
| Q1 2017 | $465,000 | +8.9% | 11,041 | -0.6% | 0.07% | +2.8% |
| Q4 2016 | $427,000 | -10.5% | 11,105 | +0.5% | 0.07% | -12.3% |
| Q3 2016 | $477,000 | +2.8% | 11,054 | +3.3% | 0.08% | +1.2% |
| Q2 2016 | $464,000 | +6.9% | 10,703 | 0.0% | 0.08% | +3.9% |
| Q1 2016 | $434,000 | -1.6% | 10,703 | -2.2% | 0.08% | -4.9% |
| Q4 2015 | $441,000 | +7.3% | 10,947 | +2.3% | 0.08% | 0.0% |
| Q3 2015 | $411,000 | +29.7% | 10,697 | +40.3% | 0.08% | +37.3% |
| Q2 2015 | $317,000 | +42.2% | 7,622 | +57.4% | 0.06% | +40.5% |
| Q1 2015 | $223,000 | +118.6% | 4,842 | +102.0% | 0.04% | +110.0% |
| Q4 2014 | $102,000 | -8.9% | 2,397 | -1.6% | 0.02% | -13.0% |
| Q3 2014 | $112,000 | -20.6% | 2,437 | -7.6% | 0.02% | -20.7% |
| Q2 2014 | $141,000 | -3.4% | 2,637 | -3.7% | 0.03% | -9.4% |
| Q1 2014 | $146,000 | +5.0% | 2,737 | +5.4% | 0.03% | +3.2% |
| Q4 2013 | $139,000 | +13.9% | 2,597 | +6.6% | 0.03% | +3.3% |
| Q3 2013 | $122,000 | -3.2% | 2,437 | -3.0% | 0.03% | -6.2% |
| Q2 2013 | $126,000 | – | 2,512 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |